Decision Return On Assets from 2010 to 2024
| DECN Stock | USD 0.0001 0.00 0.00% |
Return On Assets | First Reported 2010-12-31 | Previous Quarter (4.72) | Current Value (4.49) | Quarterly Volatility 2.16933526 |
Check Decision Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Decision main balance sheet or income statement drivers, such as Interest Expense of 32.9 M, Selling General Administrative of 2.6 M or Total Revenue of 1.7 M, as well as many exotic indicators such as Price To Sales Ratio of 2.65, Ptb Ratio of 6.01 or Days Sales Outstanding of 181. Decision financial statements analysis is a perfect complement when working with Decision Diagnostics Valuation or Volatility modules.
Decision | Return On Assets |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Decision Diagnostics Correlation against competitors. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.Note that the Decision Diagnostics information on this page should be used as a complementary analysis to other Decision Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Decision Stock analysis
When running Decision Diagnostics' price analysis, check to measure Decision Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Decision Diagnostics is operating at the current time. Most of Decision Diagnostics' value examination focuses on studying past and present price action to predict the probability of Decision Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Decision Diagnostics' price. Additionally, you may evaluate how the addition of Decision Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Decision Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.